Holen Sie sich die Stockscreener-App
3.78
4.13%
0.15
Vorhandelsmarkt:
3.71
-0.07
-1.85%
Schlusskurs vom Vortag:
$3.63
Offen:
$3.65
24-Stunden-Volumen:
554.20K
Relative Volume:
0.70
Marktkapitalisierung:
$289.49M
Einnahmen:
$4.72B
Nettoeinkommen (Verlust:
$-123.85M
KGV:
-0.2644
EPS:
-14.2981
Netto-Cashflow:
$-303.12M
1W Leistung:
+14.55%
1M Leistung:
+23.13%
6M Leistung:
+50.00%
1J Leistung:
-82.02%
1-Tages-Spanne:
$3.61
$3.84
1-Wochen-Bereich:
$3.27
$3.84
52-Wochen-Spanne:
$1.885
$4.6887
Accendra Health Inc Stock (ACH) Company Profile
Firmenname
Accendra Health Inc
Sektor
Branche
Telefon
(804) 277-4304
Adresse
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
3.78 | 289.49M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corp
|
841.31 | 98.50B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
307.99 | 59.92B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
228.72 | 53.57B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
88.26 | 10.05B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.56 | 1.34B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2024-07-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-10-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Fortgesetzt | Citigroup | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-30 | Fortgesetzt | JP Morgan | Underweight |
| 2022-03-23 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-17 | Hochstufung | UBS | Neutral → Buy |
| 2020-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-01-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2019-11-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-10 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Herabstufung | Goldman | Buy → Neutral |
| 2018-09-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Herabstufung | CLSA | Outperform → Sell |
| 2018-04-10 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Hochstufung | Goldman | Sell → Neutral |
| 2017-11-02 | Herabstufung | HSBC Securities | Buy → Hold |
| 2016-03-24 | Hochstufung | Goldman | Sell → Neutral |
| 2015-12-07 | Herabstufung | Goldman | Neutral → Sell |
| 2015-08-31 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Eingeleitet | HSBC Securities | Underweight |
| 2009-08-05 | Hochstufung | Citigroup | Sell → Buy |
| 2008-12-01 | Herabstufung | HSBC Securities | Neutral → Underweight |
Alle ansehen
Accendra Health Inc Aktie (ACH) Neueste Nachrichten
Enterprise value to EBIT forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Enterprise value to EBIT forward of Accendra Health Inc – GETTEX:6OM - TradingView
Accendra Health files prospectus for $200M mixed shelf - scanx.trade
Form S-3 Accendra Health Inc For: 15 July By Investing.com - Investing.com Nigeria
Accendra Health Files $200 Million Mixed Shelf Registration - Moomoo
Price to earnings forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health (ACH) Has Home-Care Scale, but the Debt Stack Drives the Risk - AlphaStreet
Price to earnings forward of Accendra Health Inc – SWB:6OM - TradingView
Enterprise value to revenue forward of Accendra Health Inc – SWB:6OM - TradingView
Price to sales forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Concludes Exchange Offers for Senior Notes Due 2029 and 2030 - sekbernews.id
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds - Yahoo Finance
Price to sales forward of Accendra Health Inc – SWB:6OM - TradingView
Accendra Health (ACH) Sheds 1.5% as Shares Approach Key Support ZoneLow Volume Node - dars.gov.et
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
Accendra Health Inc. Q1 2026 Earnings: EPS Beats Estimates but Stock DeclinesEarnings Turnaround - DonanımHaber
Accendra Health, Inc.(NYSE: ACH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Index - marketscreener.com
Accendra Health Inc Actuals & Estimates (NYSE:ACH) - TradingView
ACHAccendra Health Inc Options - Finviz
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Value Benchmark - marketscreener.com
Accendra Health Completes Major Exchange Offer, Restructures Debt - TipRanks
Accendra Health reports near-complete tenders in exchange offers, issues new secured notes - TradingView
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Accendra Health Reports Expiration of Exchange Offers, Final Tender Results - Moomoo
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations - Business Wire
ACH Q1 2026 Earnings: EPS Beat Drives Positive Market Response Despite Revenue UncertaintyEPS Estimate Trend - dars.gov.et
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accendra Health Inc. (ACH) Q1 2026 Earnings: Strong EPS Beat Signals Operational ImprovementFiscal Year Earnings - dars.gov.et
Accendra Health Announces Early Results of Exchange Offers and Consent Solicitations for Senior Notes - Minichart
Accendra Health Completes Major Debt Exchange and Refinancing - TipRanks
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue DisclosureEarnings Per Share - newsline.com
Accendra Health receives 99% participation in debt exchange offer - Investing.com UK
Accendra Health receives 99% participation in debt exchange offer By Investing.com - Investing.com Australia
Accendra Health Announces Early Results of Offers and Consent Solicitations - Business Wire
Accendra Health secures 99% participation in exchange offers - scanx.trade
Accendra Health (ACH) Gains 4.71% as Momentum Builds Toward Key Resistance ZoneStock Surge Alerts - dars.gov.et
Are Options Traders Betting on a Big Move in Accendra Health Stock? - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats by 60.9% but Stock Declines on Revenue UncertaintyFinancial Data - newsline.com
Accendra Health (ACH) Q4 2025 earnings summary - Quartr
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats Estimates by 60.9% as Loss Narrows to $0.04 Per ShareConsensus Forecast Report - newsline.com
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com Nigeria
Owens & Minor Appoints Jim Marshall as Chief Executive Officer, Effective May 27, 2026 - marketscreener.com
Owens & Minor names former McKesson SVP as new CEO - MassDevice
Accendra Health announces exchange offer, consent solicitations - HME News
Accendra Health Q1 2026 Earnings: EPS Beat Drives Positive Market ReactionShare Repurchase Impact - The Legal Advocate
Accendra Health launches debt exchange offer, seeks new financing By Investing.com - Investing.com Australia
Accendra Health launches debt exchange offer, seeks new financing - Investing.com UK
Finanzdaten der Accendra Health Inc-Aktie (ACH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):